Wills Eye Once Again Ranked A Premier Hospital in U.S.
Wills Eye has maintained its top tier ranking on U.S. News & World Report’s annual “Best Hospitals” Survey. For the 32nd consecutive year, Philadelphia’s specialty eye hospital was selected by ophthalmologists as one of the best places to refer patients who have the most complex eye diseases.
“It is a tremendous honor to be continuously recognized and trusted by our peers as one of the country’s very best eye hospitals. Our talented medical staff work tirelessly to remain on the cutting edge of ophthalmology and are the reason patients from all over the world get referred to Wills Eye Hospital,” said Julia A. Haller, MD, Ophthalmologist-in-Chief, Wills Eye Hospital. “Congratulations to everyone at Wills Eye and kudos to our peers who made this year’s U.S. News & World Report list.”
Four New Physicians Join Wills Eye in CPEC, Glaucoma, and Retina
Jordan D. Deaner, MD, Lauren Hock, MD, Jeffrey F. McMahon, MD, and Sarah Michelson, MD will join our medical staff–Drs. Michelson and McMahon in Cataract and Primary Eye Care (CPEC), Dr. Deaner in Retina , and Dr. Hock in Glaucoma.
Three of the four physicians are Wills Eye alumni. Drs. McMahon and Deaner both graduated from the hospital’s residency program in 2018 and 2019, respectively, and both served as Co-Chief Resident during their final year. Dr. Hock is a 2022 fellowship graduate who just completed a year of subspecialty training with the Glaucoma Service. Dr. Michelson is coming back to Philadelphia after time spent as a resident and clinical lecturer at the University of Michigan Kellogg Eye Center. Drs. McMahon and Michelson will split their time between the CPEC Service at Wills Eye Hospital and the Wills Eye Physicians offices in King of Prussia (Dr. Michelson) and Plymouth Meeting (Dr. McMahon).
Mike Wurster and Joe Frattali have been busy overseeing renovations of the Wills Eye Physicians offices of Bailey Weber and Wisner in Plymouth Meeting. The administrative facilities have undergone a transformation (pictured below) during Phase 1. Phase 2 (clinical areas, including new exam lanes), is expected to be completed by September 2022.